Friday, July 4, 2025 7/4/2025

Human B1-like Cells and Pneumococcal Defense in the Elderly

Award Number: R01AI142004
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/01/2019
PERIOD OF PERFORMANCE END DATE: 01/31/2025

Group Awards By:

View Award Description

Human B1-like Cells and Pneumococcal Defense in the Elderly - The broad, long term objective of this project is to elucidate the mechanism or mechanisms underlying the relative deficiency of serological immunity in the elderly, with particular attention to human B1-like cells and natural antibodies derived therefrom. The specific focus of the present application is to understand the age- related failure of immune defense against infection with S. pneumoniae, both at rest and after immunization with pneumococcal vaccine. A key mechanism for disposing of infectious pneumococci lies in opsonization by serum antibody, and a principal target for opsonizing antibody is phosphorylcholine (PC). Thus, we will study B cells, particularly B1-like cells, that bind PC and secrete anti-PC antibodies. It is known that human serum contains antibodies against PC, that human B1-like cells recognize PC, and that the total population of human B1-like cells declines with age. But it is not known what happens to PC-binding B1-like cells in older individuals as compared to younger individuals. In mice, where adoptive transfer experiments are possible, serum IgM derived from B1 cells of older mice fails to alter the course of pneumococcal infection in mice lacking antibody, whereas an equal amount of serum IgM from younger mice is effective. This coincides with an age-related change in the underlying nature of mouse B1 cell anti- PC antibodies as transcribed immunoglobulin becomes less germline in sequence. These reports regarding age-related changes in total human B1-like cell number and in mouse B1 cell anti-PC antibody repertoire suggest mechanisms for the failure of pneumococcal defense in older people. We hypothesize that the relative deficiency of serological immunity against PC/pneumococci in older humans, before and after pneumococcal vaccination, is due to one or more of: age-related loss of PC- binding B1-like cells, erosion of B1-like cell anti-PC antibody sequence/repertoire, and dysfunction of PC- binding B1-like cells/poor function of B1-like cell anti-PC antibodies. These characteristics have either never been studied in human B1-like cells or never been examined in antigen-specific human B1-like cells with respect to age. We will determine the validity of our hypotheses through the following aims in which we will compare older vs younger healthy donors, and older donors before and after pneumococcal vaccination. SA1. We will evaluate the level of PC-binding B1-like cells, by immunofluorescent staining for B cell subpopulations and PC-binding, followed by flow cytometry/cell sorting. SA2. We will determine the sequence/repertoire of PC-binding B1-like cell antibodies by single cell PCR followed by sequencing, cloning, and ELISA for specificity. SA3. We will evaluate the function of PC-binding B1-like cells and the antibodies they produce, by determining B1-like cell secretion with ELISPOT assays and determining anti- pneumococcal function with opsonophagocytic assays. This work will provide completely new information that will suggest new ways to improve anti-pneumococcal antibody immune defense in the elderly.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = -$876 )
2025	2023	WESTERN MICHIGAN UNIVERSITY HOMER STRYKER M.D. SCHOOL OF MEDICINE	1000 OAKLAND DR	KALAMAZOO	MI	49008	KALAMAZOO	USA	Allergy and Infectious Diseases Research	000	5	5/22/2025	NON-COMPETING CONTINUATION	-$876
														Subtotal = -$876

Issue Date FY: 2023 ( Subtotal = $377,500 )
2023	2023	WESTERN MICHIGAN UNIVERSITY HOMER STRYKER M.D. SCHOOL OF MEDICINE.	1000 OAKLAND DR	KALAMAZOO	MI	49008	KALAMAZOO	USA	Allergy and Infectious Diseases Research	000	5	1/4/2023	NON-COMPETING CONTINUATION	$377,500
														Subtotal = $377,500

Issue Date FY: 2022 ( Subtotal = $377,500 )
2022	2022	WESTERN MICHIGAN UNIVERSITY HOMER STRYKER M.D. SCHOOL OF MEDICINE.	1000 OAKLAND DR	KALAMAZOO	MI	49008	KALAMAZOO	USA	Allergy and Infectious Diseases Research	000	4	1/21/2022	NON-COMPETING CONTINUATION	$377,500
														Subtotal = $377,500

Issue Date FY: 2021 ( Subtotal = $377,500 )
2021	2021	WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE	1000 OAKLAND DR	KALAMAZOO	MI	49008	KALAMAZOO	USA	Allergy and Infectious Diseases Research	000	3	1/19/2021	NON-COMPETING CONTINUATION	$377,500
														Subtotal = $377,500

Issue Date FY: 2020 ( Subtotal = $377,500 )
2020	2020	WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE	1000 OAKLAND DR	KALAMAZOO	MI	49008	KALAMAZOO	USA	Allergy and Infectious Diseases Research	000	2	2/6/2020	NON-COMPETING CONTINUATION	$377,500
														Subtotal = $377,500

Issue Date FY: 2019 ( Subtotal = $377,500 )
2019	2019	WESTERN MICHIGAN UNIVERSITY SCHOOL OF MEDICINE	1000 OAKLAND DR	KALAMAZOO	MI	49008	KALAMAZOO	USA	Allergy and Infectious Diseases Research	000	1	1/31/2019	NEW	$377,500
														Subtotal = $377,500

Grand Total All Awards = $1,886,624

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Human B1-like Cells and Pneumococcal Defense in the Elderly

Award Number: R01AI142004

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/01/2019

PERIOD OF PERFORMANCE END DATE: 01/31/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer